Not Rated
|
Fund Size
(1.21% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 04-Nov-25 | 9995.40 | -0.05% | - | 0.20% | 133/230 |
| 1 Month | 10-Oct-25 | 10016.00 | 0.16% | - | 1.51% | 194/227 |
| 3 Month | 12-Aug-25 | 10265.30 | 2.65% | - | 5.32% | 197/224 |
| 6 Month | 12-May-25 | 11001.30 | 10.01% | - | 8.57% | 60/213 |
| YTD | 01-Jan-25 | 10127.40 | 1.27% | - | 5.47% | 132/201 |
| 1 Year | 12-Nov-24 | 10712.90 | 7.13% | 7.13% | 6.97% | 79/187 |
| 2 Year | 10-Nov-23 | 16526.80 | 65.27% | 28.42% | 20.72% | 12/141 |
| 3 Year | 11-Nov-22 | 21176.80 | 111.77% | 28.36% | 20.30% | 9/117 |
| 5 Year | 12-Nov-20 | 26729.80 | 167.30% | 21.72% | 22.41% | 43/93 |
| Since Inception | 13-Jul-18 | 43730.00 | 337.30% | 22.27% | 14.38% | 26/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 12-Nov-24 | 12000 | 12800.57 | 6.67 % | 12.54 % |
| 2 Year | 10-Nov-23 | 24000 | 28652.52 | 19.39 % | 18 % |
| 3 Year | 11-Nov-22 | 36000 | 52836.76 | 46.77 % | 26.51 % |
| 5 Year | 12-Nov-20 | 60000 | 105542.12 | 75.9 % | 22.75 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 7648 | 11.88% | 0.30% | 13.83% (Dec 2024) | 11.58% (Sep 2025) | 45.24 L | 0.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 6065.4 | 9.42% | 0.32% | 9.66% (May 2025) | 8.28% (Jan 2025) | 50.65 L | 4.32 L |
| Divis Laboratories Ltd. | Pharmaceuticals | 5474.9 | 8.50% | -0.25% | 9.23% (Aug 2025) | 1.86% (Nov 2024) | 8.13 L | -1.45 L |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 4904.1 | 7.62% | -0.63% | 8.25% (Sep 2025) | 4.87% (Jan 2025) | 43.06 L | -4.34 L |
| Cipla Ltd. | Pharmaceuticals | 4255.3 | 6.61% | -0.31% | 9.71% (Jan 2025) | 6.61% (Oct 2025) | 28.34 L | -0.32 L |
| Lupin Ltd. | Pharmaceuticals | 3474.7 | 5.40% | -0.03% | 5.44% (Aug 2025) | 3.79% (Jun 2025) | 17.70 L | 0.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 2561.4 | 3.98% | -0.07% | 4.49% (Feb 2025) | 3.83% (Jul 2025) | 4.65 L | 0.00 |
| Biocon Ltd. | Pharmaceuticals | 2113.6 | 3.28% | 0.17% | 5.02% (Jun 2025) | 1.36% (Feb 2025) | 56.80 L | 0.00 |
| Mankind Pharma Ltd. | Pharmaceuticals | 1795.1 | 2.79% | -0.16% | 4.2% (Jun 2025) | 0.62% (Nov 2024) | 7.53 L | 0.00 |
| Zydus Lifesciences Ltd. | Pharmaceuticals | 1716.2 | 2.67% | -0.11% | 4.01% (May 2025) | 2.67% (Oct 2025) | 17.61 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 3.18% |
| Margin | Margin | 0.13% |
| Net Receivables | Net Receivables | -0.41% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 5.04 | 17.45 | 54.33 | 45.87 | 39.43 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | 0.86 | 4.46 | 18.53 | 30.69 | 16.95 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 680.73 | 4.24 | 8.25 | 20.23 | 27.77 | 0.00 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1733.63 | 0.91 | 10.81 | 23.85 | 26.95 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 297.12 | 4.00 | 10.18 | 21.63 | 25.91 | 15.24 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 2.94 | 3.67 | 15.28 | 23.72 | 18.63 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7556.72 | 0.25 | 4.95 | 12.47 | 23.29 | 0.00 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 3.94 | 8.25 | 9.27 | 23.02 | 15.37 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1518.73 | 2.80 | 7.69 | 9.15 | 22.65 | 0.00 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 3.11 | 6.53 | 11.63 | 22.29 | 20.59 |
Out of 109 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 9 is/are ranked 3 * , 5 is/are ranked 2 * , 3 is/are ranked 1 * , and 78 schemes are not ranked. See more about AMC